Steve Elms is Director at ADMA BIOLOGICS, INC. (ADMA). They have made 10 open-market trades across 5 companies since 2010, most recently 2026-03-06.
CIK 0001250195
5 open-market purchases totalling $13.0M since 2013, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| LOXO | 2,038,920 | $478.5M |
| CDTX | 351,518 | $77.8M |
| ADMA | 2,045,730 | $21.9M |
| MRKR | 325,370 | $342K |
| ZSAN | 22,500 | $13K |
| PTX | 10,000 | $2K |
| MAPP | 2,030 | — |
| PrivateUnlisted | 2,516,855 | — |
| AMBI | 1,650,156 | — |
| Total | $578.5M |
Shares reported on the most recent Form 4, priced at the 2026-03-09 close. 3 holdings could not be priced and are excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ADMA | BUY | 2026-03-05 | 2026-03-09 | $15.53 | $217K | -4.3% | -37.3% | -48.7% |
| ADMA | SELL | 2025-06-12 | 2025-06-16 | $20.74 | $17.7M | -9.2% | -11.6% | -23.5% |
| MRKR | BUY | 2024-12-23 | 2024-12-26 | $3.20 | $35K | -15.6% | -43.1% | -65.8% |
| ADMA | SELL | 2024-03-18 | 2024-03-19 | $6.07 | $5.6M | +6.3% | +0.8% | +69.8% |
| ADMA | SELL | 2024-03-13 | 2024-03-15 | $6.08 | $10.2M | +11.8% | -0.8% | +78.8% |
| MRKR | BUY | 2021-03-16 | 2021-03-18 | $1.75 | $4.0M | -2.7% | -14.0% | +46.8% |
| LOXO | SELL | 2017-11-22 | 2017-11-27 | $75.00 | $37.5M | +6.7% | +15.5% | +51.0% |
| LOXO | BUY | 2014-08-06 | 2014-08-06 | $13.00 | $5.4M | -23.5% | -1.3% | -1.3% |
| AMBI | BUY | 2013-05-21 | 2013-05-21 | $8.00 | $3.4M | N/A | N/A | N/A |
| MAPP | SELL | 2010-03-10 | 2010-03-12 | $16.15 | $34K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.